Johnson & Johnson Statistics
Total Valuation
JNJ has a market cap or net worth of $417.44 billion. The enterprise value is $449.32 billion.
| Market Cap | 417.44B |
| Enterprise Value | 449.32B |
Important Dates
The last earnings date was Wednesday, July 16, 2025, before market open.
| Earnings Date | Jul 16, 2025 |
| Ex-Dividend Date | Aug 26, 2025 |
Share Statistics
JNJ has 2.41 billion shares outstanding. The number of shares has decreased by -1.32% in one year.
| Current Share Class | 2.41B |
| Shares Outstanding | 2.41B |
| Shares Change (YoY) | -1.32% |
| Shares Change (QoQ) | -0.19% |
| Owned by Insiders (%) | 0.05% |
| Owned by Institutions (%) | 73.58% |
| Float | 2.40B |
Valuation Ratios
The trailing PE ratio is 18.57 and the forward PE ratio is 15.90. JNJ's PEG ratio is 1.76.
| PE Ratio | 18.57 |
| Forward PE | 15.90 |
| PS Ratio | 4.60 |
| Forward PS | 4.39 |
| PB Ratio | 5.32 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 22.50 |
| P/OCF Ratio | 18.13 |
| PEG Ratio | 1.76 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.85, with an EV/FCF ratio of 24.22.
| EV / Earnings | 19.83 |
| EV / Sales | 4.96 |
| EV / EBITDA | 14.85 |
| EV / EBIT | 19.71 |
| EV / FCF | 24.22 |
Financial Position
The company has a current ratio of 1.01, with a Debt / Equity ratio of 0.65.
| Current Ratio | 1.01 |
| Quick Ratio | 0.68 |
| Debt / Equity | 0.65 |
| Debt / EBITDA | 1.67 |
| Debt / FCF | 2.74 |
| Interest Coverage | 27.08 |
Financial Efficiency
Return on equity (ROE) is 30.21% and return on invested capital (ROIC) is 11.76%.
| Return on Equity (ROE) | 30.21% |
| Return on Assets (ROA) | 7.61% |
| Return on Invested Capital (ROIC) | 11.76% |
| Return on Capital Employed (ROCE) | 16.38% |
| Revenue Per Employee | $656,242 |
| Profits Per Employee | $164,091 |
| Employee Count | 138,100 |
| Asset Turnover | 0.48 |
| Inventory Turnover | 2.24 |
Taxes
In the past 12 months, JNJ has paid $4.69 billion in taxes.
| Income Tax | 4.69B |
| Effective Tax Rate | 17.14% |
Stock Price Statistics
The stock price has increased by +9.08% in the last 52 weeks. The beta is 0.40, so JNJ's price volatility has been lower than the market average.
| Beta (5Y) | 0.40 |
| 52-Week Price Change | +9.08% |
| 50-Day Moving Average | 159.31 |
| 200-Day Moving Average | 155.77 |
| Relative Strength Index (RSI) | 70.40 |
| Average Volume (20 Days) | 9,483,111 |
Short Selling Information
The latest short interest is 18.27 million, so 0.76% of the outstanding shares have been sold short.
| Short Interest | 18.27M |
| Short Previous Month | 16.33M |
| Short % of Shares Out | 0.76% |
| Short % of Float | 0.76% |
| Short Ratio (days to cover) | 2.21 |
Income Statement
In the last 12 months, JNJ had revenue of $90.63 billion and earned $22.66 billion in profits. Earnings per share was $9.33.
| Revenue | 90.63B |
| Gross Profit | 62.00B |
| Operating Income | 22.80B |
| Pretax Income | n/a |
| Net Income | 22.66B |
| EBITDA | 30.26B |
| EBIT | 22.80B |
| Earnings Per Share (EPS) | $9.33 |
Balance Sheet
The company has $18.88 billion in cash and $50.76 billion in debt, giving a net cash position of -$31.88 billion or -$13.24 per share.
| Cash & Cash Equivalents | 18.88B |
| Total Debt | 50.76B |
| Net Cash | -31.88B |
| Net Cash Per Share | -$13.24 |
| Equity (Book Value) | 78.47B |
| Book Value Per Share | 32.60 |
| Working Capital | 318.00M |
Cash Flow
In the last 12 months, operating cash flow was $23.03 billion and capital expenditures -$4.48 billion, giving a free cash flow of $18.55 billion.
| Operating Cash Flow | 23.03B |
| Capital Expenditures | -4.48B |
| Free Cash Flow | 18.55B |
| FCF Per Share | $7.70 |
Margins
Gross margin is 68.41%, with operating and profit margins of 25.16% and 25.00%.
| Gross Margin | 68.41% |
| Operating Margin | 25.16% |
| Pretax Margin | 30.18% |
| Profit Margin | 25.00% |
| EBITDA Margin | 33.38% |
| EBIT Margin | 25.16% |
| FCF Margin | 20.47% |
Dividends & Yields
This stock pays an annual dividend of $5.20, which amounts to a dividend yield of 3.03%.
| Dividend Per Share | $5.20 |
| Dividend Yield | 3.03% |
| Dividend Growth (YoY) | 4.53% |
| Years of Dividend Growth | 63 |
| Payout Ratio | 54.42% |
| Buyback Yield | 1.32% |
| Shareholder Yield | 4.35% |
| Earnings Yield | 5.43% |
| FCF Yield | 4.44% |
Analyst Forecast
The average price target for JNJ is $174.64, which is 0.76% higher than the current price. The consensus rating is "Buy".
| Price Target | $174.64 |
| Price Target Difference | 0.76% |
| Analyst Consensus | Buy |
| Analyst Count | 14 |
| Revenue Growth Forecast (5Y) | 4.07% |
| EPS Growth Forecast (5Y) | 18.09% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 13, 2001. It was a forward split with a ratio of 2:1.
| Last Split Date | Jun 13, 2001 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
JNJ has an Altman Z-Score of 4.02 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.02 |
| Piotroski F-Score | 5 |